BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16897816)

  • 1. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function.
    Liang S; Zhang W; Horuzsko A
    Eur J Immunol; 2006 Sep; 36(9):2457-71. PubMed ID: 16897816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
    Harly C; Peyrat MA; Netzer S; Déchanet-Merville J; Bonneville M; Scotet E
    Blood; 2011 Mar; 117(10):2864-73. PubMed ID: 21233315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization.
    Dietrich J; Cella M; Colonna M
    J Immunol; 2001 Feb; 166(4):2514-21. PubMed ID: 11160312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
    Zhang W; Liang S; Wu J; Horuzsko A
    Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.
    Saverino D; Ghiotto F; Merlo A; Bruno S; Battini L; Occhino M; Maffei M; Tenca C; Pileri S; Baldi L; Fabbi M; Bachi A; De Santanna A; Grossi CE; Ciccone E
    J Immunol; 2004 May; 172(9):5629-37. PubMed ID: 15100307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor.
    Morel E; Bellón T
    Allergy; 2007 Feb; 62(2):190-6. PubMed ID: 17298429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.
    Valés-Gómez M; Shiroishi M; Maenaka K; Reyburn HT
    J Virol; 2005 Feb; 79(4):2251-60. PubMed ID: 15681427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
    Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
    J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance.
    Wu J; Zhang W; Hernandez-Lopez P; Fabelo E; Parikh M; Mulloy LL; Horuzsko A
    Hum Immunol; 2009 Dec; 70(12):988-94. PubMed ID: 19664670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.
    Ince MN; Harnisch B; Xu Z; Lee SK; Lange C; Moretta L; Lederman M; Lieberman J
    Immunology; 2004 Aug; 112(4):531-42. PubMed ID: 15270723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.
    Young NT; Uhrberg M; Phillips JH; Lanier LL; Parham P
    J Immunol; 2001 Mar; 166(6):3933-41. PubMed ID: 11238638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
    Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
    Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
    von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
    Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling.
    Nikolova M; Musette P; Bagot M; Boumsell L; Bensussan A
    Blood; 2002 Aug; 100(3):1019-25. PubMed ID: 12130517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.
    Prod'homme V; Griffin C; Aicheler RJ; Wang EC; McSharry BP; Rickards CR; Stanton RJ; Borysiewicz LK; López-Botet M; Wilkinson GW; Tomasec P
    J Immunol; 2007 Apr; 178(7):4473-81. PubMed ID: 17372005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages.
    Lamar DL; Weyand CM; Goronzy JJ
    Blood; 2010 Apr; 115(16):3278-86. PubMed ID: 20194892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.
    Anfossi N; Doisne JM; Peyrat MA; Ugolini S; Bonnaud O; Bossy D; Pitard V; Merville P; Moreau JF; Delfraissy JF; Dechanet-Merville J; Bonneville M; Venet A; Vivier E
    J Immunol; 2004 Dec; 173(12):7223-9. PubMed ID: 15585844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
    Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
    Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.